Home » Newsletters » BioWorld Science

BioWorld Science

July 11, 2022

View Archived Issues

Novel murine model of NASH-driven HCC developed

Researchers mimic human acute-on-chronic liver failure on rat

Potent capsid assembly modulators show promise in mouse model of HBV infection

Nanjing Shijiang Medicine Technology patents new compounds for cancer

H. Lundbeck A/S discloses new NMDA glycine-site receptor modulators

Novel momelotinib analogue shows promising preclinical efficacy as pan-JAK inhibitor

Gritscience Biopharmaceuticals describes new casein kinase inhibitors

RVX-201 shows protection against recurrent HSV-2 disease in guinea pig model

Aditxt reports promising safety profile of immunotherapeutic drug ADI-100

XuanZhu Pharma identifies new AhR antagonists

Sunshine Lake Pharma synthesizes new GTPase KRAS inhibitors

Discovery of novel gut-selective NaPi2b inhibitor with lower hydrophobicity and improved efficacy

Mcpip1 deletion model useful to study endothelial activation during chronic inflammation

Calpain inhibitor BLD-3051 shows promising results in preclinical liver fibrosis

Vaccines targeting MICA/B designed for efficacy against tumors resistant to cytotoxic T cells

Condensates cross disease states, study finds

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...